Dr. Kerner serves as EXUMA Biotechnology’s Director of New Product Planning and Portfolio Management and has been with the company since November 2016. She is currently responsible for portfolio management, market sizing, opportunity analysis, patient access, and medical communications for EXUMA’s programs in the US and Asia. Prior to EXUMA, she was an Engagement Manager for Boston Strategic Partners (BSP), a healthcare consulting firm in Boston, MA, where she managed projects in all three of the firm’s practices: Business Strategy, Health Economics and Outcomes Research, and Medical Communications. Dr. Kerner has extensive experience engaging and recruiting key opinion leaders and has worked on various types of projects including drug pricing and reimbursement strategy, market sizing, financial forecasting, competitive landscape assessments, publication planning, and strategic marketing. Dr. Kerner earned her B.S. degree in Chemical Engineering from the Massachusetts Institute of Technology and her M.S. and Ph.D. degrees in Biomedical Engineering from the University of Michigan. While at BSP, she participated in several mentoring and networking programs for women in STEM fields such as the Healthcare Businesswomen’s Association Mentoring Program and the GWAMIT (Graduate Women at MIT) Mentoring Program.
Alissa Kerner, Ph.D.Director, New Product Planning & Portfolio Management